- Home
- PPL vs ILMN Comparison
PPL vs ILMN Comparison
Compare PPL & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPL
- ILMN
- Stock Information
- Founded
- PPL 1920
- ILMN 1998
- Country
- PPL United States
- ILMN United States
- Employees
- PPL N/A
- ILMN N/A
- Industry
- PPL Electric Utilities: Central
- ILMN Medical Specialities
- Sector
- PPL Utilities
- ILMN Health Care
- Exchange
- PPL Nasdaq
- ILMN Nasdaq
- Market Cap
- PPL 25.2B
- ILMN 22.9B
- IPO Year
- PPL N/A
- ILMN 2000
- Fundamental
- Price
- PPL $34.16
- ILMN $140.10
- Analyst Decision
- PPL Buy
- ILMN Buy
- Analyst Count
- PPL 10
- ILMN 20
- Target Price
- PPL $35.50
- ILMN $160.68
- AVG Volume (30 Days)
- PPL 5.1M
- ILMN 2.2M
- Earning Date
- PPL 11-01-2024
- ILMN 11-04-2024
- Dividend Yield
- PPL 3.03%
- ILMN N/A
- EPS Growth
- PPL 1.20
- ILMN N/A
- EPS
- PPL 1.11
- ILMN N/A
- Revenue
- PPL $8,282,000,000.00
- ILMN $4,390,000,000.00
- Revenue This Year
- PPL $0.71
- ILMN N/A
- Revenue Next Year
- PPL $0.63
- ILMN $4.28
- P/E Ratio
- PPL $30.64
- ILMN N/A
- Revenue Growth
- PPL N/A
- ILMN N/A
- 52 Week Low
- PPL $25.35
- ILMN $97.36
- 52 Week High
- PPL $35.15
- ILMN $156.66
- Technical
- Relative Strength Index (RSI)
- PPL 56.26
- ILMN 50.00
- Support Level
- PPL $33.87
- ILMN $138.88
- Resistance Level
- PPL $35.15
- ILMN $145.37
- Average True Range (ATR)
- PPL 0.50
- ILMN 4.83
- MACD
- PPL -0.06
- ILMN 0.13
- Stochastic Oscillator
- PPL 55.33
- ILMN 77.38
About PPL PPL Corporation
PPL is a holding company of regulated utilities in Pennsylvania, Kentucky, and Rhode Island. The Pennsylvania regulated delivery and transmission segment distributes electricity to customers in central and eastern Pennsylvania. LG&E and KU are involved in regulated electricity generation, transmission, and distribution in Kentucky. The Kentucky utilities also serve gas customers. Rhode Island Energy operates electric and gas utilities in Rhode Island.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.